The privacy of personal health information is increasingly at risk. The European Union is responding to this risk with a new data privacy law, the General Data Protection Regulation (GDPR), which will go into effect in May 2018. The GDPR sets out strong new patient privacy regulations, including an expanded scope of who must protect the data of European patients, a requirement for more easily understandable patient consent materials and significant penalties for data privacy violations.

Are you prepared for this new regulation? How can it affect your clinical trials? Should you be concerned?

In this webinar, we’ll clarify details of the new regulations and how they’ll affect companies that conduct clinical trials in Europe (including those who do not operate in Europe but might enroll European citizens in their trials elsewhere). We’ll discuss the three biggest changes associated with the new regulation and how they could have serious implications for your clinical trials.

Watch now